Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 2Pharmathen SA
02 3APGDI
03 1Ajanta Pharma Limited
04 2Alkem Laboratories
05 2Alter Laboratories Sa
06 2Apotex Inc
07 19Astellas Pharma
08 1Aurobindo Pharma Limited
09 1Avansor Pharma Oy
10 1Cinfa
11 2Cipla Medpro South Africa
12 1GSK
13 2KMS Health Center
14 1LABORATORIOS NORMON SA
15 2Lupin Ltd
16 2Qilu Pharmaceutical
17 2STADA Arzneimittel
18 2Sawai Pharmaceutical Co
19 2Tecnimede
20 2Teva Pharmaceutical Industries
21 2Unichem Laboratories Limited
22 1Whanin Pharmaceutical
23 2Zentiva
24 2Zydus Pharmaceuticals
01 9Depot tablet
02 2ER Tablet
03 8Extended-Release Tablet
04 2FCT
05 1FOR SUSPENSION, EXTENDED RELEASE;ORAL
06 1Granules
07 4Prolonged Release Tablet
08 2Prolonged Release Tablets
09 2TAB
10 2TABLET (EXTENDED-RELEASE)
11 1TABLET, EXTENDED RELEASE
12 15TABLET, EXTENDED RELEASE;ORAL
13 10Tablet
01 2Allowed
02 8Approved
03 8Authorized
04 4DISCN
05 6Generic
06 2Originator
07 2Prescription
08 11RX
09 16Blank
01 1Baxirto
02 1Bemiga SR
03 15Betmiga
04 1Betmiga 25 mg
05 1Betmiga 50 mg
06 1Iretig
07 14MIRABEGRON
08 4MYRBETRIQ
09 1MYRBETRIQ GRANULES
10 1Mirabegron Advances
11 1Mirabegron Alter
12 1Mirabegron Cinfamed
13 1Mirabegron Glenmark
14 1Mirabegron Normon
15 2Mirabegron Stada
16 2Mirabegron Teva
17 1Mirabegron Zentiva
18 1Urton 25
19 1Urton 50
20 8Blank
01 2Canada
02 2Greece
03 4India
04 9Norway
05 2Portugal
06 4South Africa
07 1South Korea
08 8Spain
09 8Sweden
10 2Switzerland
11 17USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 218172
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ GRANULES
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG/ML
Packaging :
Approval Date : 2021-03-25
Application Number : 213801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209413
Regulatory Info :
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-06-30
Application Number : 217989
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-06-30
Application Number : 217989
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2019-12-27
Application Number : 209446
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-05-06
Application Number : 217061
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
